Abstract
To present key aspects and strategies for use of insulin therapy in patients with type 1 diabetes mellitus. Limitations and advantages of various insulin regimens are discussed, and issues pertaining to insulin analogues are reviewed. Rapid-acting insulin analogues provide better and safer postprandial glucose coverage than does human regular insulin. Premixed insulin preparations do not provide the flexibility to address the individual needs of patients adequately to control postprandial glucose excursions. Because of its peak, short duration, and high variability, NPH insulin is inappropriate for patients with type 1 diabetes and patients with type 2 diabetes who require continuous basal coverage. Continuous infusion of soluble insulin by means of an insulin pump is currently the most physiologic approach available for treatment of type 1 diabetes. Use of insulin glargine or insulin detemir with a rapid-acting insulin analogue at meals is an effective and reasonable alternative to insulin pump therapy. Both rapid-acting and long-acting insulin analogues improve glycemic control. This improvement involves controlling hemoglobin A1c levels, reducing glucose excursions, and decreasing hypoglycemia, particularly during the night....Continue Reading
References
Mar 1, 1996·Diabetologia·J MarkussenI Jonassen
Sep 1, 1996·Diabetes Care·E TorloneG Bolli
Apr 30, 2003·Diabetes Care·Paolo RossettiGeremia B Bolli
Jan 27, 2004·Current Medical Research and Opinion·John E Gerich
Citations
Feb 23, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Matthias ElsnerSigurd Lenzen
Apr 13, 2011·Acta Physiologica·I Brock JacobsenJ E Henriksen
Mar 20, 2013·BMC Complementary and Alternative Medicine·Clautilde Mofor TeugwaDenis Zofou
Dec 7, 2007·Primary Care·Jeff Unger
Jun 19, 2007·Obstetrics and Gynecology Clinics of North America·Charanpal Singh, Lois Jovanovic
Feb 23, 2013·IEEE Transactions on Bio-medical Engineering·A RevertJ Bondia
Jun 3, 2015·Pediatric Transplantation·Molly O RegelmannRonen Arnon
Jun 6, 2013·International Journal of Endocrinology·Wen-Shan LvYan-Yan Gao
Sep 20, 2008·Physical Therapy·Eric Arthur Gulve
Jun 2, 2010·Journal of Diabetes Science and Technology·Neesha RamchandaniSvetlana Ten
Jan 1, 2007·Journal of Diabetes Science and Technology·David C Klonoff
Jan 15, 2010·International Journal of Radiation Biology·Yong Bin ChenG Z Guo
Feb 24, 2007·Diabetes Technology & Therapeutics·Reinhard H A Becker
Jun 24, 2021·Journal of Biomedical Informatics·Laura EvansMatvey B Palchuk